-
Private credit risks remain at large
Regulators and investors should pay attention to the strain in the direct loan market
-
US government debt hits $40tn as borrowing rises at historic rate
Public spending surges despite Donald Trump’s vow to stabilise America’s public finances
-
Fed officials express rising concern over persistently high inflation
Minutes from July central bank meeting show ‘many’ policymakers are prepared to increase borrowing costs
-
Can weight-loss drugs lose their nasty side effects?
Pharma groups seek new generation of GLP-1 medicines as some patents start to expire
-
Moderna’s cancer shot: exciting for investors, inconclusive for patients
A glimmer of hope for sufferers, a potential revenue platform for a cash-burner, and a whole heap of unknowns
-
US Treasury to double buybacks of long-term government debt
Sharp sell-off in recent weeks has sent borrowing costs soaring
-
Moderna shares double on melanoma vaccine trial success
Drugmaker’s cancer shot developed with Merck delivers positive outcome in late-stage trial
-
Europe should wish Marco Rubio a bright future
Americans who support reckless wars are sometimes also the likeliest to defend Europe
0161 413 0666
